Jaguar Health Launches First Canine Cancer Registry in the U.S. and Canine Cancer Care Index

Jaguar Health today announced the launch of Canine Cancer: Take charge (VSanine Hhealth An/a Randgistry Exchange), a one-of-a-kind national canine cancer registry and the Canine Cancer Care Index to provide the veterinary community and dog owners with important incidence and prevalence data to help guide the diagnosis of canine cancer and treatment decisions. Launched on the first National Canine Cancer Awareness Day and co-sponsored by Jaguar Animal Health; TogoRun, a global health communications agency; and Ivee, a software company focused on animal health data, the program will initially access canine cancer information from 2 key sources: a nationally representative, multi-year Gallup survey of dog owners in the United States and a retrospective study of over 35,000 anonymous canine patient records uploaded to a secure personalized database with over 830 confirmed cancer diagnoses.

The Gallup survey, conducted in March 2022, estimated the prevalence – the percentage of American dogs with cancer in 2021 – to be 3.4%, lower than the prevalence of around 5% in humans this year. -the. The survey also found that the incidence – the percentage of US dogs newly diagnosed with cancer in 2021 – was 2.8%, about 5 times the incidence of 0.57% newly diagnosed cancer in dogs. man that year. This finding is significant because the researchers assumed that canine cancer rates mirrored human cancer rates.

” We established Take charge to fill a major research gap within the veterinary and dog owner community in the United States as, to date, there has been no national dog owner survey or registry focused on canine cancer,” Lisa Conte, founder and CEO of Jaguar Health, said in a press release from the organization. “The information of Take charge will provide the first-ever national representation of the incidence and prevalence of canine cancer and help inform decisions that improve the quality of life for dogs with cancer and their owners. The data may also provide information to help better understand cancer in humans.

Other key findings from the Gallup survey include:

  • More than 8 in 10 dog owners support the creation of a canine cancer registry to better understand the disease and advance treatments
  • 68% of participating dog owners decided not to treat their dog for cancer due to their dog’s age (54%), cost of treatment (39%), adverse effects of treatment (38%) or other reasons
  • Of all responding dog owners, 92% indicated that they had no pet insurance at the time of diagnosis.
  • Nearly 3 in 4 parents of dogs who had canine cancer in the past 10 years were satisfied or very satisfied with their overall experience during treatment, although only 39% said their dog was cured or in remission
  • Although 46% of dog owners “strongly agree” that their pet received high-quality cancer care, only 30% strongly agree that they knew what to do with cancer. expect during their dog’s cancer treatment.
  • When asked to imagine how difficult it would be for members of their household to manage various side effects related to chemotherapy, the percentage of all dog owners rating it as difficult or very difficult was: pain (60%), urinary incontinence (43%), diarrhea (41%), vomiting/nausea (39%) and fatigue/lethargy/lack of energy (19%)
  • Canine cancer treatment has a major impact on the well-being of dog owners, including depression, anxiety, lack of sleep, and absence of work or other obligations; for example, 63% of respondents said they felt a lot of stress and 58% said they felt down and depressed during their dog’s cancer.
  • The ability of dog owners to manage their dog’s adverse effects related to cancer treatment, such as pain, urinary incontinence and diarrhea, is the strongest predictor of key pet owner wellness outcomes. .
  • However, many dog ​​parents find managing the side effects of treatment particularly difficult:
  • 92% of dog owners with no experience of canine cancer and 65% of those with experience of canine cancer said they knew little or nothing about adverse effects.
  • Only 22% of respondents “strongly agree” that they managed the side effects of their dog’s cancer treatment well, and only 29% have a clear understanding of the potential side effects of treatment.
  • Having a veterinarian who cares about a dog’s comfort, high quality care, and a thorough explanation of treatment options were the most critical to overall treatment satisfaction, while managing side effects was the most important factor to determine the negative impact of canine cancer on dog parents. ‘ welfare

Canine Cancer Care Index

In addition to assessing the incidence and prevalence of canine cancer, as well as dog owners’ perceptions, emotions, and experiences related to canine cancer, Gallup used the survey data to calculate a Cancer Care Index. canine cancer which reflects 3 dimensions related to care against canine cancer: knowledge, quality of care and canine comfort. Ranging from 0 (the worst possible score) to 100 (the best possible score), the index will help assess whether canine cancer care experiences are getting better, worse, or staying the same for dog owners and their dogs over time. Gallup has determined that the baseline for the Canine Cancer Care Index is 80.5 or a B-, indicating a clear need for improvement.

“Protecting dogs from cancer starts with knowing its impact by breed, type, age, sex and location,” said Terry Fossum, DVM, MS, PhD, ACVS Diplomat, Take charge Co-Chair of the Scientific Advisory Board (SAB), in a press release from the organization. “The United States has lagged behind other countries where there are multiple canine health registries and there have been several attempts by other groups to establish a US registry without success. We need to do better for our dogs, and we believe Take charge will finally give us the tools we need to advance canine cancer care.

Take charge Scientific Advisory Board

the Take charge SAB includes 8 leading US veterinarians specializing in canine oncology and surgery. One of the council’s activities is to promote the adoption of a consistent canine cancer diagnostic coding system and to support the goals of the National Institutes of Health/National Cancer Institute’s Comparative Oncology Program. Comparative oncology is the study of naturally occurring cancers in companion dogs and other animals as models for human cancers. It provides a new approach to generate new information about cancer, for example environmental risk factors, genetic determinants and the evaluation of new treatment approaches. In support of comparative oncology, the SAB encourages veterinary clinics to adopt coding practices that align with the first edition of the International Veterinary Classification of Diseases for Canine Oncology, or Vet-ICD-O- canine-1, which is largely based on the most recent version of the human cancer coding system, ICD-O-3.2.

“The heart of any cancer registry is its cancer coding system,” said SAB Co-Chair Craig Clifford, DVM, MS, DACVIM (Oncology), in an organizational press release. “As we continue to improve the Take charge registry, we will include Vet-ICD-O-canine-1 as it is a comprehensive, user-friendly and easily accessible resource for veterinarians, researchers and specialists. This will allow us to make more “apples to apples” comparisons of canine cancers in the United States and other countries and regions, which will help us better understand and treat canine cancer. »

the Take charge SAB members include SAB Co-Chairs Clifford and Theresa (Terry) W. Fossum, DVM, MS, PhD, Diplomate ACVS; as well as Susan Ettinger, DVM, DACVIM (Oncology); Trina Hazzah, DVM, DACVIM (oncology), CVCH; Chad M. Johannes, DVM, DACVIM (SAIM, Oncology); Doug Thamm, VMD, ACVIM graduate (oncology); David Vail, DVM, MS, DACVIM (oncology); and Rachel Venable, DVM, MS, DACVIM (oncology).

Take charge Website

Registry data will be publicly available via an interactive and easy-to-use dashboard on the Take charge website, with open access for clinical practitioners and academics to all canine cancer medical record data for research purposes. The registry will continue to grow as veterinary clinics and pet owners upload the medical records of dogs with cancer at no cost to the clinic or the pet owner. Data is anonymized, anonymized and protected in accordance with the guidelines of the General Data Protection Regulation (GDPR) to ensure the confidentiality of participant information.

Take charge will also focus on raising awareness of canine cancer by promoting the first National Canine Cancer Awareness Day – to be held annually on May 23 – so that dog owners have access to the latest information on the types of cancers by breed, symptoms and treatment options.

“Recent advances in chemotherapy, as well as advances in chemotherapy management [adverse] adverse effects such as diarrhea, should be discussed with canine veterinarians and oncologists to ensure dogs benefit from the latest scientific advances in canine cancer,” Ettinger said in a press release from the organization.

TakeC.HARGE Launch Event

Dog owners and members of the veterinary community are encouraged to visit TakeChargeRegistry.com for more information, including how to download canine cancer medical records and how clinics can participate in the registry. The public is also invited to a special event and performance by Broadway stars, including Oscar-nominated actor Chazz Palminteri and Grammy-winning actress Jenn Colella, at Madison Square Park in New York City, New York today today from 12:30 p.m. to 2:30 p.m. EDT to celebrate the launch of Take charge Those unable to attend the event can still watch virtually on Facebook.

Reference

Jaguar Health announces the launch of the first US Canine Cancer Registry and Canine Cancer Care Index. Press release. Jaguar Health. May 23, 2022.

Comments are closed.